American Heart Journal
Volume 150, Issue 2 , Pages 227-233 , August 2005

Association between cardiac troponin T elevation and angioscopic morphology of culprit lesion in patients with non–ST-segment elevation acute coronary syndrome

  • Tomohito Ohtani, MD

      Affiliations

    • Cardiovascular Division, Osaka Police Hospital, Osaka, Japan
    • ,
  • Yasunori Ueda, MD, PhD

      Affiliations

    • Cardiovascular Division, Osaka Police Hospital, Osaka, Japan
    • Corresponding Author InformationReprint requests: Yasunori Ueda, MD, PhD, Cardiovascular Division, Osaka Police Hospital, 10-31 Kitayama-cho, Tennoji-ku, Osaka 543-0035, Japan.
    • ,
  • Masahiko Shimizu, MD

      Affiliations

    • Cardiovascular Division, Osaka Police Hospital, Osaka, Japan
    • ,
  • Isamu Mizote, MD

      Affiliations

    • Cardiovascular Division, Osaka Police Hospital, Osaka, Japan
    • ,
  • Atushi Hirayama, MD, PhD

      Affiliations

    • Cardiovascular Division, Osaka Police Hospital, Osaka, Japan
    • ,
  • Masatsugu Hori, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita, Japan
    • ,
  • Kazuhisa Kodama, MD, PhD

      Affiliations

    • Cardiovascular Division, Osaka Police Hospital, Osaka, Japan

Received 13 April 2004 ,Accepted 14 September 2004.

References 

  1. Bhayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem. 1995;28:1–293
  2. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med. 1996;335:1333–1341
  3. Newby LK, Christenson RH, Ohman EM, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation. 1998;98:1853–1859
  4. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non–ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001;286:2405–2412
  5. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation. 1996;93:1651–1657
  6. Heidenreich PA, Alloggiamento T, Melsop K, et al. The prognostic value of troponin in patients with non–ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001;38:478–485
  7. Frey N, Dietz A, Kurowski V, et al. Angiographic correlates of a positive troponin t test in patients with unstable angina. Crit Care Med. 2001;29:1130–1136
  8. Heeschen C, van Den Brand MJ, Hamm CW, et al. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation. 1999;100:1509–1514
  9. Wong GC, Morrow DA, Murphy S, et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis in Myocardial Infarction. Circulation. 2002;106:202–207
  10. Jurlander B, Farhi ER, Banas JJ, et al. Coronary angiographic findings and troponin T in patients with unstable angina pectoris. Am J Cardiol. 2000;85:810–814
  11. Lindahl B, Diderholm E, Lagerqvist B, et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol. 2001;38:979–986
  12. den Heijer P, Foley DP, Escaned J, et al. Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. J Am Coll Cardiol. 1994;24:649–654
  13. Franzen D, Sechtem U, Hopp HW. Comparison of angioscopic, intravascular ultrasonic, and angiographic detection of thrombus in coronary stenosis. Am J Cardiol 1998;82:1273-1275, A9
  14. Ueda Y, Asakura M, Hirayama A, et al. Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction: serial angioscopic observations. J Am Coll Cardiol. 1996;27:606–610
  15. Braunwald E. Unstable angina. A classification. Circulation. 1989;80:410–414
  16. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  17. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J. 2002;144:981–986
  18. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol. 2001;37:1284–1288
  19. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;711:699–708
  20. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354–1363
  21. Zhao XQ, Therooux P, Snapinn SM, et al. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina, or non–Q wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms). PRISM-PLUS Investigators. Circulation. 1999;100:1609–1615
  22. Feld S, Ganim M, Carell ES, et al. Comparison of angioscopy, intravascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients. J Am Coll Cardiol. 1996;28:97–105
  23. Waxman S, Sassower MA, Mittleman MA, et al. Angioscopic predictors of early adverse outcome after coronary angioplasty in patients with unstable angina and non–Q wave myocardial infarction. Circulation. 1996;93:2106–2113
  24. De Feyter PJ, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation. 1995;92:1408–1413
  25. Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet. 1991;337:809–812
  26. Mizuno K, Satomura K, Miyamoto A, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med. 1992;326:287–291
  27. Thieme T, Wernecke KD, Meyer R, et al. Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol. 1996;28:1–6
  28. Nesto RW, Waxman S, Mittleman MA, et al. Angioscopy of culprit lesions in unstable angina: correlation of clinical presentation with plaque morphology. Am J Cardiol. 1998;81:225–228
  29. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–671
  30. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570–580
  31. Gavin JB, Maxwell L, Edgar SG. Microvascular involvement in cardiac pathology. J Mol Cell Cardiol. 1998;30:2531–2540
  32. Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol. 2000;85:50B–60B
  33. Okamatsu K, Takano M, Sakai S, et al. Elevated troponin T levels and lesion characteristics in non–ST-elevation acute coronary syndromes. Circulation. 2004;109:465–470
  34. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol. 2000;36:970–1062
  35. Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol. 1997;29:43–48
  36. Hamm CW, Heeschen C, Goldman B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. C7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med. 1999;340:1623–1629
  37. Johnson PA, Goldman L, Sacks DB, et al. Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain. Am Heart J. 1999;137:1137–1144

PII: S0002-8703(04)00764-1

doi: 10.1016/j.ahj.2004.09.051

American Heart Journal
Volume 150, Issue 2 , Pages 227-233 , August 2005

Article Tools

* Image Usage & Resolution